AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
DEFERASIROX in Côte d'Ivoire
3 products registered with AIRP — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| OLEPTISS 90 MG COMPRIME PELLICULE BOITE DE 30 | MD/5O1223/0107 | LABORATOIRE NOVARTIS OVERSEAS INVESTMENT AG LICHTSTRASSE 35 4056 BAILE | active | — |
| OLEPTISS 180 MG COMPRIME PELLICULE BOITE DE 30 | MD/5O1223/0108 | LABORATOIRE NOVARTIS OVERSEAS INVESTMENT AG LICHTSTRASSE 35 4056 BAILE | active | — |
| OLEPTISS 360 MG COMPRIME PELLICULE BOITE DE 30 | MD/5O1223/0109 | LABORATOIRE NOVARTIS OVERSEAS INVESTMENT AG LICHTSTRASSE 35 4056 BAILE | active | — |
DEFERASIROX — AIRP Registration Details
AIRP (Côte d'Ivoire) has 3 registered products containing DEFERASIROX, of which 3 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track DEFERASIROX registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.